Results 101 to 110 of about 615,741 (238)

Efficacy and safety of the emedastine patch, a novel transdermal drug delivery system for allergic rhinitis: Phase III, multicenter, randomized, double-blinded, placebo-controlled, parallel-group comparative study in patients with seasonal allergic rhinitis

Allergology International, 2018
Background: The emedastine patch was developed in Japan as the first transdermal drug delivery system of emedastine difumarate for allergic rhinitis.
Kimihiro Okubo, Eiji Uchida, Takaaki Terahara, Katsuhiko Akiyama, Shigeo Kobayashi, Yusuke Tanaka   +5 more
doaj   +1 more source

Intranasal ciclesonide for allergic rhinitis

, 2008
Ben Williams, William B Smith, Frank E KetteDepartment of Clinical Immunology and Allergy, Royal Adelaide Hospital, Adelaide, South AustraliaAbstract: Ciclesonide is a novel corticosteroid which is optimized for topical use.
Ben Williams, Frank E Kette, William B Smith   +2 more
core  

D-2-Hydroxyglutarate Attenuates Sinonasal Inflammation in Murine Allergic Rhinitis

Introduction: Allergic rhinitis (AR) is largely driven by IgE-induced immune cell activation, which promotes allergen-induced upper airway inflammation. The regulatory mechanisms of IgE synthesis in AR are poorly understood.
Anuj Tharakan, Daniel H. Conrad, Ankit Kumar, Carmen Camarena, Rebecca K. Martin   +4 more
core   +1 more source

Online public concern about allergic rhinitis and its association with COVID-19 and air quality in China: an informative epidemiological study using Baidu index

BMC Public Health
Background Allergic rhinitis is a common health concern that affects quality of life. This study aims to examine the online search trends of allergic rhinitis in China before and after the COVID-19 epidemic and to explore the association between the ...
Yi Yu, Qinzhun Zhang, Xinmeng Yao, Jinghua Wu, Jialu He, Yinan He, Huaqiang Jiang, Dongxin Lu, Chengyin Ye   +8 more
doaj   +1 more source

At-a-glance - Pollens, climate and allergies: Quebec initiatives

Health Promotion and Chronic Disease Prevention in Canada, 2019
Pollen allergies are a major source of seasonal allergic rhinitis in North America. This type of rhinitis affects 17% of adults in Quebec, a marked increase in the last 30 years. Ragweed (Ambrosia artemisiifolia L.) pollens are responsible for 50% to 90%
Isabelle Demers, Pierre Gosselin
doaj   +1 more source

Combined intranasal treatment for allergic rhinitis: an option for children under 12 years of age [PDF]

Exploration of Asthma & Allergy
Intranasal treatments combining corticosteroids with antihistamines are a safe and effective alternative for treating moderate to severe seasonal allergic rhinitis in children over 12 years of age and adults.
Alberto Vidal, Pedro Cortez
doaj   +1 more source

Subcutaneous Allergen Immunotherapy With Thermosensitive Hydrogel and Recombinant Birch Pollen Allergen Variant, a Randomised Controlled Trial

Clinical &Experimental Allergy, EarlyView.
A Phase 1, randomised, placebo‐controlled, dose‐escalation trial was performed with 30 birch pollen allergic subjects treated with DM‐101PX, that contains a recombinant hypoallergenic variant of Bet v 1 formulated with poloxamer 338 thermosensitive hydrogel.
Anna Nilson, Patricia Couroux, Jaana Haka, Silja Halme, Pekka Mattila, R. J. Joost van Neerven, Rolien Pels‐Rijcken, Janneke Ruinemans‐Koerts, Yvonne Schmidt‐Hieltjes, Anne Marie Salapatek, Kati Sallinen, Kristiina Takkinen, Daphne Tsitoura, Dirk‐Jan Opstelten, Juha Rouvinen   +14 more
wiley   +1 more source

Quantitative Assessment of Allergic Shiners in Children with Allergic Rhinitis

, 2011
Background: The knowledge on allergic shiners is extremely limited. A conceivable tool able to quantify allergic shiners has not been established. Objectives: We sought to determine the significance and changeability of allergic shiners through our newly
CHEN, CHIEN-HAN;LIN, YU-TSAN;WANG, LI-CHIEH;CHIU, SHIH-HSUAN;YANG, YAO-HSU;LEE, JYH-HONG;CHIANG, BOR-LUEN, 陳建翰;林于粲;王麗潔;邱士軒;楊曜旭;李志鴻;江伯倫   +1 more
core   +1 more source

Inflammatory Factors in Allergic Rhinitis: A 20‐Year Bibliometric Mapping and Emerging Trends

Flavour and Fragrance Journal, Volume 41, Issue 5, Page 1076-1089, September 2026.
This figure illustrates the bibliometric process and results of research on inflammatory factors of allergic rhinitis from 2004 to 2024 including data screening, global distribution, collaborative networks and the evolution of research hotspots. ABSTRACT Allergic rhinitis (AR) is driven by a network of inflammatory mediators released by mast cells ...
Shanshan Jing, Fengying Zhang, Qiqi Liu
wiley   +1 more source

Stapokibart (CM310): A review in seasonal allergic rhinitis

American Journal of Otolaryngology
Stapokibart (CM310), a humanized anti-IL-4Rα monoclonal antibody, blocks IL-4/IL-13 signaling for type 2 inflammatory diseases like seasonal allergic rhinitis (SAR), where standard of care often fails.Assess stapokibart's efficacy on the primary endpoint (reflective Total Nasal Symptom Score, rTNSS) and safety as add-on therapy in SoC-inadequate ...
Ping, Xue, Jing, Yan, Jianwei, Li
openaire   +2 more sources